Search research articles
Contact Us
Filters
Showing results (41-50 of 55) with videos related to
Page
of 6
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Linmiao Jiang, Jan Walewski, et al.
The American Journal of Surgical Pathology
|
December 13, 2018
Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA
Clémentine Sarkozy, Christiane Copie-Bergman, Diane Damotte, et al.
British Journal of Haematology
|
November 12, 2019
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
Laurane Cottin, Jérémie Riou, Corentin Orvain, et al.
The Lancet. Haematology
|
September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Leukemia
|
September 15, 2025
Molecular profiling and risk stratification in solitary bone plasmacytoma
Barbara Burroni, Stéphanie Harel, Raphaele Seror, et al.
Gastroenterology
|
April 19, 2026
CLONAL LYMPHOCYTE EXPANSIONS AND JAK-STAT PATHWAY MUTATIONS DEFINE A PATHOGENIC CONTINUUM DRIVING RESISTANCE TO GLUTEN-FREE DIET IN CELIAC DISEASE
Georgia Malamut, Nicolas Guégan, Francesco Carbone, et al.
Haematologica
|
December 30, 2021
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, et al.
Medicina (Kaunas, Lithuania)
|
March 26, 2022
Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature
Margot Denier, Sarah Tick, Romain Dubois, et al.
Blood Cancer Journal
|
April 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag, et al.
Nature Communications
|
January 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
Olivier Kosmider, Céline Possémé, Marie Templé, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 55) with videos related to
Sort By:
Page
of 6
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 5, 2022
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
Olivier Hermine, Linmiao Jiang, Jan Walewski, et al.
The American Journal of Surgical Pathology
|
December 13, 2018
Gray-zone Lymphoma Between cHL and Large B-Cell Lymphoma: A Histopathologic Series From the LYSA
Clémentine Sarkozy, Christiane Copie-Bergman, Diane Damotte, et al.
British Journal of Haematology
|
November 12, 2019
Sequential mutational evaluation of CALR -mutated myeloproliferative neoplasms with thrombocytosis reveals an association between CALR allele burden evolution and disease progression
Laurane Cottin, Jérémie Riou, Corentin Orvain, et al.
The Lancet. Haematology
|
September 24, 2020
Molecular response after obinutuzumab plus high-dose cytarabine induction for transplant-eligible patients with untreated mantle cell lymphoma (LyMa-101): a phase 2 trial of the LYSA group
Steven Le Gouill, Asma Beldi-Ferchiou, Marion Alcantara, et al.
Leukemia
|
September 15, 2025
Molecular profiling and risk stratification in solitary bone plasmacytoma
Barbara Burroni, Stéphanie Harel, Raphaele Seror, et al.
Gastroenterology
|
April 19, 2026
CLONAL LYMPHOCYTE EXPANSIONS AND JAK-STAT PATHWAY MUTATIONS DEFINE A PATHOGENIC CONTINUUM DRIVING RESISTANCE TO GLUTEN-FREE DIET IN CELIAC DISEASE
Georgia Malamut, Nicolas Guégan, Francesco Carbone, et al.
Haematologica
|
December 30, 2021
Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study
Amira Marouf, Anne Segolene Cottereau, Salim Kanoun, et al.
Medicina (Kaunas, Lithuania)
|
March 26, 2022
Hidden in the Eyes-Recurrence of Systemic Hemopathies Reportedly "In Remission": Six Cases and Review of Literature
Margot Denier, Sarah Tick, Romain Dubois, et al.
Blood Cancer Journal
|
April 24, 2025
Validation of POD24 as a robust early clinical indicator of poor survival in mantle cell lymphoma from 1280 patients on clinical trials, a LYSA study
Clémentine Sarkozy, Loïc Chartier, Vincent Ribrag, et al.
Nature Communications
|
January 30, 2024
VEXAS syndrome is characterized by inflammasome activation and monocyte dysregulation
Olivier Kosmider, Céline Possémé, Marie Templé, et al.
Page
of 6